LR-5182

LR-5182 is a stimulant drug which acts as a norepinephrine–dopamine reuptake inhibitor, structurally related to the better known drug fencamfamine.^[1][2][3] It was developed by the pharmaceutical company Eli Lilly in the 1970s, and researched for potential use as an antidepressant, although never marketed. LR-5182 has two stereoisomers, both of which are active, although one isomer blocks reuptake of only dopamine and noradrenaline, while the other blocks reuptake of serotonin as well.^[4]

Other names(cis)-LR-5182, (cis)-LR-5182 hydrochloride

CAS Number

• HCl: 62373-97-1

PubChem CID

• 44024
• HCl: 44023

ChemSpider

• 40076
• HCl: 40075

Quick facts Clinical data, Other names ...

LR-5182

Clinical data
Other names	(cis)-LR-5182, (cis)-LR-5182 hydrochloride
Identifiers
IUPAC name 1-[(2R,3S)-3-(3,4-dichlorophenyl)-2-bicyclo[2.2.2]octanyl]-N,N-dimethylmethanamine
CAS Number	HCl: 62373-97-1
PubChem CID	44024 HCl: 44023
ChemSpider	40076 HCl: 40075
ChEMBL	ChEMBL322067
CompTox Dashboard (EPA)	DTXSID601027508
Chemical and physical data
Formula	C17H23Cl2N
Molar mass	312.28 g·mol−1
3D model (JSmol)	Interactive image HCl: Interactive image
SMILES CN(C)C[C@@H]1C2CCC(CC2)[C@@H]1c3ccc(Cl)c(Cl)c3 HCl: [Cl-].C[NH+](C)C[C@@H]1C2CCC(CC2)[C@@H]1c3ccc(Cl)c(Cl)c3
InChI InChI=1S/C17H23Cl2N/c1-20(2)10-14-11-3-5-12(6-4-11)17(14)13-7-8-15(18)16(19)9-13/h7-9,11-12,14,17H,3-6,10H2,1-2H3/t11?,12?,14-,17-/m1/s1 Key:JOQQHMGSIKNGAF-HLFYOVGASA-N HCl: InChI=1S/C17H23Cl2N.ClH/c1-20(2)10-14-11-3-5-12(6-4-11)17(14)13-7-8-15(18)16(19)9-13;/h7-9,11-12,14,17H,3-6,10H2,1-2H3;1H/t11?,12?,14-,17-;/m1./s1 Key:CWRRQXXGIKGNJA-PQTJMFGHSA-N
(verify)

Close

While LR-5182 itself never proceeded beyond initial animal studies, discovery of monoamine reuptake inhibition activity and stimulant effects in drugs of this type has subsequently led to the development of many other stimulant drugs of related chemical structure, primarily developed as potential antidepressants,^[5] or as substitute drugs for the treatment of cocaine abuse.^[6][7]